{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T13:19:04Z","timestamp":1784035144427,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To determine the incidence of postoperative cystoid macular edema (CME) following pars plana vitrectomy (PPV) with epiretinal membrane (ERM) peeling, and to evaluate the anatomical and functional response to intravitreal dexamethasone implant (Ozurdex; AbbVie) in affected eyes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective, single-center cohort study included 92 consecutive eyes with idiopathic ERM that underwent PPV with ERM peeling by a single surgeon. Eyes were allocated to a control group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200984), comprising eyes without postoperative CME, or to a CME group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20098), comprising eyes that developed postoperative CME confirmed on swept-source optical coherence tomography (SS-OCT) and subsequently received intravitreal dexamethasone implant (DEX). Best-corrected visual acuity (BCVA, logMAR), central macular thickness (CMT, \u00b5m), and intraocular pressure (IOP, mmHg) were assessed preoperatively and postoperatively in both groups, and before and after DEX implantation in the CME group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The incidence of postoperative CME requiring treatment was 8.7%. Most baseline characteristics were comparable between groups, although preoperative IOP was significantly lower in the CME group. CMT decreased significantly after surgery in both the control group (335.1\u2009\u00b1\u200937.3 to 289.5\u2009\u00b1\u200922.9\u00a0\u03bcm;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and the CME group (382.9\u2009\u00b1\u200974.6 to 310.9\u2009\u00b1\u200922.9\u00a0\u03bcm;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.033); however, postoperative CMT remained significantly higher in the CME group than in controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.034). DEX implantation produced an additional significant CMT reduction (379.9\u2009\u00b1\u200967.1 to 302.7\u2009\u00b1\u200935.3\u00a0\u03bcm;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), reducing the between-group difference to a non-significant level (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.332). BCVA improved significantly after surgery in the control group (0.32\u2009\u00b1\u20090.26 to 0.04\u2009\u00b1\u20090.10 logMAR;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) but not in the CME group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.582). Following DEX implantation, BCVA improved significantly in the CME group (0.47\u2009\u00b1\u20090.35 to 0.22\u2009\u00b1\u20090.25 logMAR;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), approaching values observed in the control group (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.078). IOP remained stable in controls (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.576). A transient but significant IOP increase was observed in the CME group after surgery (11.5\u2009\u00b1\u20092.7 to 15.3\u2009\u00b1\u20093.7 mmHg;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019), with no further change after DEX implantation (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.747).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Postoperative CME requiring treatment occurred in approximately 1 in 11 eyes following PPV with ERM peeling and was associated with significant anatomical and functional impairment. The present findings suggest that intravitreal dexamethasone implant was associated with improvement in selected cases of postoperative CME without additional impact on IOP; however, larger prospective studies are required to confirm these results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00888-1","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:44:06Z","timestamp":1782207846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative cystoid macular edema after pars plana vitrectomy for epiretinal membrane: incidence, anatomical and functional outcomes, and response to intravitreal dexamethasone implant"],"prefix":"10.1186","volume":"12","author":[{"given":"Leonardo Provetti","family":"Cunha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela Ferreira","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Cabral","family":"Zacharias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rony Carlos","family":"Preti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Virg\u00ednia Ferreira","family":"Costa-Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio Luiz Ribeiro","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"2","key":"888_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0002-9394(86)90589-1","volume":"101","author":"H Hirokawa","year":"1986","unstructured":"Hirokawa H, Jalkh AE, Takahashi M, Trempe CL, Schepens CL. Role of the vitreous in idiopathic preretinal macular fibrosis. Am J Ophthalmol. 1986;101(2):166\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"888_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/bjo.80.4.323","volume":"80","author":"R Grewing","year":"1996","unstructured":"Grewing R, Mester U. Results of surgery for epiretinal membranes and their recurrences. Br J Ophthalmol. 1996;80(4):323\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"888_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0161-6420(02)01443-4","volume":"110","author":"S Fraser-Bell","year":"2003","unstructured":"Fraser-Bell S, Guzowski M, Rochtchina E, Wang JJ, Mitchell P. Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology. 2003;110(1):34\u201340.","journal-title":"Ophthalmology"},{"issue":"6","key":"888_CR4","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajo.2010.06.006","volume":"150","author":"M Inoue","year":"2010","unstructured":"Inoue M, Morita S, Watanabe Y, Kaneko T, Yamane S, Kobayashi S, et al. Inner segment\/outer segment junction assessed by spectral-domain optical coherence tomography in patients with idiopathic epiretinal membrane. Am J Ophthalmol. 2010;150(6):834\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"888_CR5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ophtha.2009.08.034","volume":"117","author":"CI Falkner-Radler","year":"2010","unstructured":"Falkner-Radler CI, Glittenberg C, Hagen S, Benesch T, Binder S. Spectral-domain optical coherence tomography for monitoring epiretinal membrane surgery. Ophthalmology. 2010;117(4):798\u2013805.","journal-title":"Ophthalmology"},{"issue":"6","key":"888_CR6","first-page":"1219","volume":"31","author":"T Kinoshita","year":"2011","unstructured":"Kinoshita T, Imaizumi H, Okushiba U, Miyamoto H, Ogino N. Time course of changes in visual acuity and foveal thickness after surgery for idiopathic epiretinal membrane. Retina. 2011;31(6):1219\u201325.","journal-title":"Retina"},{"issue":"3","key":"888_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ophtha.2012.09.003","volume":"120","author":"TL Jackson","year":"2013","unstructured":"Jackson TL, Donachie PHJ, Sparrow JM, Johnston RL. United Kingdom National Ophthalmology Database study of vitreoretinal surgery: Report 1; case mix, complications, and cataract. Ophthalmology. 2013;120(3):628\u201334.","journal-title":"Ophthalmology"},{"issue":"9","key":"888_CR8","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ophtha.2017.03.060","volume":"124","author":"A Govetto","year":"2017","unstructured":"Govetto A, Lalane RA 3rd, Sarraf D, Figueroa MS, Hubschman JP. Insights into epiretinal membranes: presence of ectopic inner foveal layers and a new optical coherence tomography staging scheme. Ophthalmology. 2017;124(9):1412\u201322.","journal-title":"Ophthalmology"},{"issue":"3","key":"888_CR9","first-page":"371","volume":"124","author":"WC Chang","year":"2017","unstructured":"Chang WC, Lin C, Lee CH, Sung TL, Tung TH, Liu JH. Vitrectomy with or without internal limiting membrane peeling for idiopathic epiretinal membrane: a meta-analysis. Ophthalmology. 2017;124(3):371\u20138.","journal-title":"Ophthalmology"},{"issue":"6","key":"888_CR10","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1177\/1120672120980951","volume":"31","author":"EM Karasavvidou","year":"2021","unstructured":"Karasavvidou EM, Panos GD, Koronis S, Kozobolis VP, Tranos PG. Optical coherence tomography biomarkers for visual acuity in patients with idiopathic epiretinal membrane. Eur J Ophthalmol. 2021;31(6):3203\u201313.","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"888_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00417-014-2684-5","volume":"253","author":"SW Park","year":"2015","unstructured":"Park SW, Byon IS, Lee JE, Oum BS. Analysis of the ganglion cell layer and photoreceptor layer using optical coherence tomography after idiopathic epiretinal membrane surgery. Graefes Arch Clin Exp Ophthalmol. 2015;253(2):207\u201314.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"888_CR12","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0161-6420(01)00856-9","volume":"108","author":"R Tadayoni","year":"2001","unstructured":"Tadayoni R, Paques M, Massin P, Mouki-Benani S, Mikol J, Gaudric A. Dissociated optic nerve fiber layer appearance of the fundus after idiopathic epiretinal membrane removal. Ophthalmology. 2001;108(12):2279\u201383.","journal-title":"Ophthalmology"},{"key":"888_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ajo.2018.08.037","volume":"196","author":"D Zur","year":"2018","unstructured":"Zur D, Iglicki M, Feldinger L, et al. Disorganization of retinal inner layers as a biomarker for idiopathic epiretinal membrane after macular surgery: the DREAM study. Am J Ophthalmol. 2018;196:129\u201335.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"888_CR14","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1097\/IAE.0000000000003087","volume":"41","author":"DH Lee","year":"2021","unstructured":"Lee DH, Park SE, Lee CS. Microcystic macular edema and cystoid macular edema before and after epiretinal membrane surgery. Retina. 2021;41(8):1652\u20139.","journal-title":"Retina"},{"issue":"1","key":"888_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40942-024-00542-8","volume":"10","author":"AMF Matos","year":"2024","unstructured":"Matos AMF, Defina RLS, Costa-Cunha LVF, Zacharias LC, Preti RC, Monteiro MLR, et al. Correlation between retinal sensitivity assessed by microperimetry and structural abnormalities on optical coherence tomography after successful epiretinal membrane surgery. Int J Retina Vitreous. 2024;10(1):24.","journal-title":"Int J Retina Vitreous"},{"issue":"5","key":"888_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ajo.2010.05.037","volume":"150","author":"J Kim","year":"2010","unstructured":"Kim J, Rhee KM, Woo SJ, Yu YS, Chung H, Park KH. Long-term temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal membrane. Am J Ophthalmol. 2010;150(5):701\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"888_CR17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1159\/000522263","volume":"245","author":"HJ Chen","year":"2022","unstructured":"Chen HJ, Hsiao CH, Chang CJ. Efficacy of combined vitrectomy with intravitreal corticosteroid injection for idiopathic epiretinal membrane removal on anatomical and functional outcomes: a meta-analysis. Ophthalmologica. 2022;245(3):218\u201329.","journal-title":"Ophthalmologica"},{"issue":"5","key":"888_CR18","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1097\/IAE.0b013e318229b1f7","volume":"32","author":"JH Ahn","year":"2012","unstructured":"Ahn JH, Park HJ, Lee JE, Oum BS. Effect of intravitreal triamcinolone injection during vitrectomy for idiopathic epiretinal membrane. Retina. 2012;32(5):892\u20136.","journal-title":"Retina"},{"issue":"5","key":"888_CR19","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1177\/11206721241226469","volume":"34","author":"D Su","year":"2024","unstructured":"Su D, Li HN, Chen QC, Shen DP, Huang ZT. Impact of intravitreal triamcinolone injection following epiretinal membrane peeling on ectopic inner foveal layer classification. Eur J Ophthalmol. 2024;34(5):1541\u20137.","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"888_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3928\/23258160-20160229-05","volume":"47","author":"Y Yonekawa","year":"2016","unstructured":"Yonekawa Y, Mammo DA, Thomas BJ, Wolfe JD, Hassan TS. A comparison of intraoperative dexamethasone intravitreal implant and triamcinolone acetonide used during vitrectomy and epiretinal membrane peeling: a case-control study. Ophthalmic Surg Lasers Imaging Retina. 2016;47(3):232\u20137.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"5","key":"888_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/IAE.0000000000001627","volume":"38","author":"G Guidi","year":"2018","unstructured":"Guidi G, Casini G, Ripandelli G, Piaggi P, Dalle Lucche F, Sartini M, et al. Residual intraretinal edema after 25-gauge vitrectomy and macular pucker removal: is intraoperative sustained-release dexamethasone a real treatment option? Retina. 2018;38(5):993\u20139.","journal-title":"Retina"},{"issue":"9","key":"888_CR22","first-page":"54","volume":"10","author":"Y Yonekawa","year":"2015","unstructured":"Yonekawa Y, Wolfe JD. Dexamethasone intravitreal implant: pharmacology and clinical update. Retina Today. 2015;10(9):54\u20138.","journal-title":"Retina Today"},{"issue":"10","key":"888_CR23","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/IAE.0000000000003537","volume":"42","author":"X Yang","year":"2022","unstructured":"Yang X, Wang Z, Yu Y, et al. Clinical features and prognosis in idiopathic epiretinal membranes with different types of intraretinal cystoid spaces. Retina. 2022;42(10):1874\u201382.","journal-title":"Retina"},{"issue":"6","key":"888_CR24","doi-asserted-by":"publisher","first-page":"e0253323","DOI":"10.1371\/journal.pone.0253323","volume":"16","author":"MLR Monteiro","year":"2021","unstructured":"Monteiro MLR, Sousa RM, Ara\u00fajo RB, et al. Diagnostic ability of confocal near-infrared reflectance fundus imaging to detect retrograde microcystic maculopathy from chiasm compression: a comparative study with OCT findings. PLoS ONE. 2021;16(6):e0253323.","journal-title":"PLoS ONE"},{"issue":"11","key":"888_CR25","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1097\/IAE.0000000000002266","volume":"39","author":"M Dysli","year":"2019","unstructured":"Dysli M, Ebneter A, Menke MN, et al. Patients with epiretinal membranes display retrograde maculopathy after surgical peeling of the internal limiting membrane. Retina. 2019;39(11):2132\u201340.","journal-title":"Retina"},{"issue":"6","key":"888_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0008-4182(03)80023-6","volume":"38","author":"E Mandelcorn","year":"2003","unstructured":"Mandelcorn E, Khan Y, Javorska L, Cohen J, Howarth D, Mandelcorn M. Idiopathic epiretinal membranes: cell type, growth factor expression, and fluorescein angiographic and retinal photographic correlations. Can J Ophthalmol. 2003;38(6):457\u201363.","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"888_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.preteyeres.2005.09.001","volume":"25","author":"C Harada","year":"2006","unstructured":"Harada C, Mitamura Y, Harada T. The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cells. Prog Retin Eye Res. 2006;25(2):149\u201364.","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"888_CR28","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1097\/IAE.0000000000000105","volume":"34","author":"C Furino","year":"2014","unstructured":"Furino C, Boscia F, Recchimurzo N, Sborgia C, Alessio G. Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker. Retina. 2014;34(8):1612\u20136.","journal-title":"Retina"},{"issue":"2","key":"888_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3928\/23258160-20150213-01","volume":"46","author":"LS Taney","year":"2015","unstructured":"Taney LS, Baumal CR, Duker JS. Sustained-release dexamethasone intravitreal implant for persistent macular edema after vitrectomy for epiretinal membrane. Ophthalmic Surg Lasers Imaging Retina. 2015;46(2):224\u20138.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"4","key":"888_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000464259","volume":"237","author":"LO Hattenbach","year":"2017","unstructured":"Hattenbach LO, Springer-Wanner C, Hoerauf H, et al. Intravitreal sustained-release steroid implants for the treatment of macular edema following surgical removal of epiretinal membranes. Ophthalmologica. 2017;237(4):232\u20137.","journal-title":"Ophthalmologica"},{"key":"888_CR31","first-page":"5832186","volume":"2018","author":"YC Chang","year":"2018","unstructured":"Chang YC, Liu PK, Kao TE, Wu HJ, Cheng KC, Chen KJ, et al. Dexamethasone intravitreal implant (Ozurdex) for long-term macular edema after epiretinal membrane peeling surgery. J Ophthalmol. 2018;2018:5832186.","journal-title":"J Ophthalmol"},{"issue":"4","key":"888_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.oret.2021.10.008","volume":"6","author":"R Mahmoudzadeh","year":"2022","unstructured":"Mahmoudzadeh R, Israilevich R, Salabati M, et al. Pars plana vitrectomy for idiopathic epiretinal membrane: OCT biomarkers of visual outcomes in 322 eyes. Ophthalmol Retina. 2022;6(4):308\u201317.","journal-title":"Ophthalmol Retina"},{"issue":"7","key":"888_CR33","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/bjophthalmol-2014-306159","volume":"99","author":"D Bellocq","year":"2015","unstructured":"Bellocq D, Korobelnik JF, Burillon C, et al. Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br J Ophthalmol. 2015;99(7):979\u201383.","journal-title":"Br J Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00888-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00888-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00888-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:46:58Z","timestamp":1784033218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00888-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["888"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00888-1","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Universidade Federal de Juiz de Fora (CEP\/UFJF; approval number 3.919.662; CAAE: 12296919.0.3002.0065) and conducted in accordance with the tenets of the Declaration of Helsinki. Given its retrospective nature, general informed consent was waived by the ethics committee. All patients in the CME group provided additional individual written informed consent prior to off-label use of the intravitreal dexamethasone implant (Ozurdex; AbbVie), as this indication is not approved by ANVISA in Brazil. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors consent to the publication of this paper in this Journal. Not applicable for individual patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Leonardo Provetti Cunha, MD, PhD \u2013 Associate Professor of Ophthalmology at the Juiz de Fora Medical School, Federal University of Juiz de Fora; Head of the Retina and Vitreous Service at Hospital de Olhos Juiz de Fora; Professor in the Postgraduate Program, Department of Ophthalmology, University of S\u00e3o Paulo, Brazil. Manuela Ferreira Guimar\u00e3es \u2013 Medical student, Faculdade de Ci\u00eancias M\u00e9dicas e da Sa\u00fade de Juiz de Fora, Brazil. Leandro Cabral Zacharias, MD, PhD \u2013 Professor in the Postgraduate Program, Department of Ophthalmology, University of S\u00e3o Paulo, Brazil. Rony Carlos Preti, MD, PhD \u2013 Professor in the Postgraduate Program, Department of Ophthalmology, University of S\u00e3o Paulo, Brazil. Luciana Virg\u00ednia Ferreira Costa-Cunha, MD, PhD \u2013 Head of the Cataract Service at Hospital de Olhos Juiz de Fora, Brazil. M\u00e1rio Luiz Ribeiro Monteiro, MD, PhD \u2013 Full Professor, Department of Ophthalmology, University of S\u00e3o Paulo, Brazil.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}}],"article-number":"99"}}